These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1796293)

  • 1. Fibrinolysis: past and present, a reflection of fifty years.
    Astrup T
    Semin Thromb Hemost; 1991 Jul; 17(3):161-74. PubMed ID: 1796293
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
    Sindet-Pedersen S
    Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis.
    Faulk WP; Labarrere CA; Nelson DR; Pitts D
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S158-64. PubMed ID: 8719478
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tissue-type plasminogen activator (T-PA). Structure and function].
    Pietrucha T; Cierniewski CS
    Acta Haematol Pol; 1992; 23(3):157-64. PubMed ID: 1492540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profibrinolytic and antifibrinolytic effects of platelets.
    Devine DV; Carter CJ
    Coron Artery Dis; 1995 Dec; 6(12):915-22. PubMed ID: 8723012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased peritoneal tissue plasminogen activator during prolonged laparoscopic surgery.
    Brokelman WJ; Holmdahl L; Janssen IM; Falk P; Bergström M; Klinkenbijl JH; Reijnen MM
    J Surg Res; 2009 Jan; 151(1):89-93. PubMed ID: 18541262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice.
    Jang YC; Tsou R; Gibran NS; Isik FF
    Surgery; 2000 Jun; 127(6):696-704. PubMed ID: 10840366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in fibrinolysis mediated by vascular endothelial cells].
    Zhou QS
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):318-22. PubMed ID: 2129251
    [No Abstract]   [Full Text] [Related]  

  • 11. Visceral fat as a determinant of fibrinolysis and hemostasis.
    Mertens I; Van Gaal LF
    Semin Vasc Med; 2005 Feb; 5(1):48-55. PubMed ID: 15968580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet, blood coagulation and fibrinolysis.
    Marckmann P
    Dan Med Bull; 1995 Nov; 42(5):410-25. PubMed ID: 8747799
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasminogen tissue activator and plasminogen tissue inhibitor in type II diabetes].
    Rość D; Drewniak W; Kotschy M; Graczykowska-Koczorowska A; Raukuć D
    Pol Merkur Lekarski; 1997 Jan; 2(7):24-5. PubMed ID: 9296893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass.
    de Haan J; Schönberger J; Haan J; van Oeveren W; Eijgelaar A
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1017-23. PubMed ID: 8246533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolysis process in prostatic carcinoma].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):107-8. PubMed ID: 8756748
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the activity of indicators of the fibrinolytic system on assessment of the hemostatic state].
    Savchuk OM; Hamisoniia MSh; Kizim OI; Platonova TM
    Fiziol Zh (1994); 2001; 47(3):58-63. PubMed ID: 11519252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catecholamines and activation of fibrinolysis].
    Zhu GJ
    Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):62-4. PubMed ID: 1648257
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical and physiologic principles of tissue-type plasminogen activator].
    Lill H
    Z Gesamte Inn Med; 1987 Sep; 42(17):478-86. PubMed ID: 3120429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peritoneal mesothelium--the role in fibrin transformations].
    Winckiewicz M; Staniszewski R; Połubińska A; Breborowicz A
    Przegl Lek; 2006; 63(9):778-81. PubMed ID: 17479869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The macrophage and fibrinolysis.
    Loscalzo J
    Semin Thromb Hemost; 1996; 22(6):503-6. PubMed ID: 9122715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.